WAYLIVRA® (volanesorsen)



To view full EU summary of product characteristics for WAYLIVRA, please visit www.ema.europa.eu/en

Waylivra is not approved for any use and is not commercially available in the United States or other markets outside the European Union.




Akcea Therapeutics has been acquired by Ionis Pharmaceuticals. For continued news and information about Akcea Therapeutics, please visit ionispharma.com. You are being redirected, please wait. If you have not been redirected in 30 seconds, please click the button below.

Go to ionispharma.com